Analyzing the Future of Flowable Hemostats Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
How has the flowable hemostats market size evolved in recent years?
The market size of flowable hemostats has seen robust growth in the past few years. It is expected to expand from a worth of $0.95 billion in 2024 to $1.02 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. This upward trajectory during the historical period is due to factors such as an increase in elective surgeries, growing implementation of personalized medicine, a surge in healthcare expenditure, and development of healthcare infrastructure in evolving markets.
What are the predictions for the flowable hemostats market size in the coming years?
The market size for flowable hemostats is predicted to experience robust growth in the coming years, expanding to $1.37 billion by 2029 with a CAGR of 7.6%. The underlying factors for this expected growth over the forecast period include an escalation in surgical procedures, increasing chronic disease prevalence, a rising demand for minimally invasive surgeries, and an aging population with a need for surgical care. The key trends projected for this period involve the incorporation of advanced bioengineered materials, the design of intelligent hemostatic products, cutting-edge robotic-assisted and minimally invasive surgical techniques, the uptake of patient-tailored hemostatic options, and sophisticated customization of hemostats.
Get your flowable hemostats market report here!
https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report
What key factors are fueling the growth of the flowable hemostats market?
The expansion of the flowable hemostats market is expected to be driven by the rising number of surgical procedures. The frequency of surgeries is escalating due to the growing elderly population, which necessitates age-related surgeries, and innovations that have rendered surgeries quicker and more attainable. Flowable hemostats are particularly advantageous during surgery as they help manage bleeding in areas that are challenging to reach or where conventional methods may not work effectively. For example, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional NGO, published a report in June 2024 stating that in 2023, the total count of surgical and non-surgical procedures had increased by 3.4%, totaling 34.9 million, relative to the prior year. Consequently, the incremental number of surgical procedures is propelling growth in the flowable hemostats market.
How is the global flowable hemostats market divided into key segments?
The flowable hemostats market covered in this report is segmented –
1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats
2) By Material: Porcine Gelatin, Bovine Gelatin
3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications
4) By End User: Hospital And Clinics, Ambulatory Surgery Centers
Subsegments:
1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats
2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats
3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20552&type=smp
Who are the key firms paving the way for growth in the flowable hemostats market?
Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.
Which trends are expected to transform the flowable hemostats market?
Major corporations in the flowable hemostats market are striving to develop state-of-the-art hemostatic agents, including no-swell technologies, that cater to the changing necessities of surgical methods. No-swell technology is a characteristic of a hemostatic agent that stops it from absorbing fluids and expanding, hence it is apt for surgeries where swelling could trigger complications. For example, in January 2023, Medcura Inc., a US-based surgical technology firm, earned a breakthrough device designation from the Food and Drug Administration (FDA) for their LifeGel technology which quells bleeding during surgical procedures where swelling is unacceptable. Medcura’s LifeGel stands alone as the only flowable hemostatic gel constructed to tackle specific issues regarding hemostatic swelling. This absorbent agent refrain from swelling as it is fully hydrated and prepared for use, possibly lessening the dangers linked to swelling, such as nerve injury and paralysis. With cost-effectiveness, antimicrobial properties preservation, relative transparency, and the ability to mucoadhere to tissues, it provides a safer and superior solution for halting bleeding during intricate surgical operations.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20552
What regions are contributing significantly to the growth of the flowable hemostats market?
North America was the largest region in the flowable hemostats market in 2024. The regions covered in the flowable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Hemostats Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report
Gastrointestinal Bleeding Treatment Devices Size Global Market Report 2025
Bleeding Disorders Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
